Clinical presentation and extent of resection impacts progression-free survival in spinal ependymomas
Journal of Neuro-Oncology · 2024
DOI: 10.1007/s11060-024-04623-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuro-Oncology, 2024. Verfasst von Mark A Davison und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Ependymoma, Spinal Cord Neoplasms, Neurosurgical Procedures, Progression-Free Survival. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Primary treatment of spinal ependymomas involves surgical resection, however recurrence ranges between 50 and 70%. While the association of survival outcomes with lesion extent of resection (EOR) has been studied, existing analyses are limited by small samples and archaic data resulting in an inhomogeneous population. We investigated the relationship between EOR and survival outcomes, chiefly overall survival (OS) and progression-free survival (PFS), in a large contemporary cohort of spinal ependymoma patients.
Methods
Adult patients diagnosed with a spinal ependymoma from 2006 to 2021 were identified from an institutional registry. Patients undergoing primary surgical resection at our institution, ≥ 1 routine follow-up MRI, and pathologic diagnosis of ependymoma were included. Records were reviewed for demographic information, EOR, lesion characteristics, and pre-/post-operative neurologic symptoms. EOR was divided into 2 classifications: gross total resection (GTR) and subtotal resection (STR). Log-rank test was used to compare OS and PFS between patient groups.
Results
Sixty-nine patients satisfied inclusion criteria, with 79.7% benefitting from GTR. The population was 56.2% male with average age of 45.7 years, and median follow-up duration of 58 months. Cox multivariate model demonstrated significant improvement in PFS when a GTR was attained ( p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
- Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
- Department of Anatomic Pathology, The Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
- Department of Neurosurgery, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. angelol@ccf.org.
- Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, USA. angelol@ccf.org.
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA. angelol@ccf.org.
Zitieren
APA
Davison, M. A., Lilly, D. T., Patel, A. A., Kashkoush, A., Chen, X., Wei, W., Benzel, E. C., Prayson, R. A., Chao, S., & Angelov, L. (2024). Clinical presentation and extent of resection impacts progression-free survival in spinal ependymomas. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04623-4
Vancouver
Davison MA, Lilly DT, Patel AA, Kashkoush A, Chen X, Wei W, et al. Clinical presentation and extent of resection impacts progression-free survival in spinal ependymomas. Journal of Neuro-Oncology. 2024. doi:10.1007/s11060-024-04623-4
BibTeX
@article{Davison2024,
author = {Davison, Mark A and Lilly, Daniel T and Patel, Arpan A and Kashkoush, Ahmed and Chen, Xiaoying and Wei, Wei and Benzel, Edward C and Prayson, Richard A and Chao, Samuel and Angelov, Lilyana},
title = {Clinical presentation and extent of resection impacts progression-free survival in spinal ependymomas},
journal = {Journal of Neuro-Oncology},
year = {2024},
doi = {10.1007/s11060-024-04623-4}
}
EUVIMED